Table 2 Profile of de-identified patient samples used in mammary intraductal injection studies.

From: Expression of CCL2/CCR2 signaling proteins in breast carcinoma cells is associated with invasive progression

Patient sample

Diagnosis

Biomarker

ER

PR

HER2

IC-041717-1

DCIS low grade

+ 100%

+ 40%

NA

IC-031317

DCIS high grade, comedo/solid

+ 5%

−

NA

IC-022316

DCIS intermediate grade, micropapillary/sold

+ 99%

+ 68%

+

  1. Patient diagnosis, ER, PR, HER2 data were provided in pathology reports. IC-041717-1 and IC-031317 were obtained by needle core biopsy. IC-022316 were obtained through surgical biopsy.
  2. NA information not available.
Back to article page